Deze website maakt gebruik van cookies. We gebruiken cookies om instellingen te onthouden en je bezoek soepeler te laten verlopen. Daarnaast gebruiken we ook cookies voor de verbetering van de website en het verzamelen en analyseren van statistieken. Lees meer over cookies

Home
Britt Vervoort

Britt Vervoort

Postdoc

Rios groep

Telefoon 088-9727682

E-mail B.M.T.Vervoort@prinsesmaximacentrum.nl

IKZF1 gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia
- jun. 2024
- Britt M T, Vervoort, et al
- Haematologica
Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways
- sep. 2022
- Miriam, Butler, et al
- Frontiers in Oncology
BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway
- dec. 2021
- Miriam, Butler, et al
- Blood
The transcriptional repressor SNAI2 impairs neuroblastoma differentiation and inhibits response to retinoic acid therapy
- mrt. 2020
- Kirsten S, Vrenken, et al
- Biochimica et biophysica acta. Molecular basis of disease

Bekijk alle publicaties

Britt Vervoort

Publicaties

IKZF1 gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia

Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways

BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway

The transcriptional repressor SNAI2 impairs neuroblastoma differentiation and inhibits response to retinoic acid therapy